# Steris **Source:** https://geo.sig.ai/brands/steris **Vertical:** Healthcare Tech **Subcategory:** Sterilization & Infection Prevention **Tier:** Leader **Website:** steris.com **Last Updated:** 2026-04-14 ## Summary Steris plc (STE) reported ~$5.5B revenue in FY2024. Global leader in sterilization, decontamination, and infection prevention products and services for healthcare and life sciences. HQ: Dublin / Mentor, OH. ## Company Overview STERIS plc is the global leader in sterilization, reprocessing, and decontamination services and products for the healthcare and life sciences industries. The company provides the steam sterilizers, hydrogen peroxide sterilizers, endoscope reprocessors, and facility cleaning products that make surgical equipment safe to reuse — a critical but often invisible part of healthcare operations. STERIS also offers sterilization contract services for medical device manufacturers, processing implants, surgical instruments, and single-use devices at over 60 facilities worldwide. STERIS reported approximately $5.5 billion in revenue in FY2024, spanning four segments: Healthcare (products and services for hospitals and outpatient surgery centers), Life Sciences (sterilization for pharma and device manufacturing), Applied Sterilization Technologies (AST, outsourced contract sterilization), and Dental. The company's competitive advantage is deep customer integration: STERIS equipment is specified in hospital facility designs and infection prevention protocols, creating high switching costs as replacement requires retraining, regulatory updates, and significant capital. Service contracts for maintaining and validating sterile processing equipment add recurring revenue. The 2021 acquisition of Cantel Medical added dental infection prevention and endoscope reprocessing to STERIS's portfolio. AST's contract sterilization facilities — using gamma radiation and ethylene oxide (EO) — are essential infrastructure for medical device manufacturers who lack in-house sterilization capability. Regulatory pressure on EO emissions is creating capital investment requirements for facility upgrades, but also raises barriers to entry for would-be competitors. ## Frequently Asked Questions ### What does STERIS do? STERIS provides sterilization equipment and services for hospitals (making surgical instruments safe to reuse), plus contract sterilization for medical device manufacturers and pharmaceutical companies. It also makes infection prevention products for dental and life sciences applications. ### Why is STERIS hard to replace in hospitals? STERIS sterilization equipment is built into hospital sterile processing department designs and specified in infection prevention protocols. Switching to a competitor requires facility modifications, retraining staff, and regulatory updates — creating near-permanent customer relationships. ### What is STERIS's ticker? STERIS plc trades on the NYSE under the ticker STE. ### What is contract sterilization? Medical device manufacturers often lack in-house sterilization capability and outsource to STERIS's Applied Sterilization Technologies (AST) facilities, which use gamma radiation, ethylene oxide, or electron beam sterilization to process finished devices before they are shipped to hospitals. ### What sterilization methods does STERIS Applied Sterilization Technologies use? STERIS Applied Sterilization Technologies (AST) uses four primary methods: ethylene oxide (EO) gas for heat-sensitive devices like catheters and pacemakers, gamma radiation for single-use disposables and packaging materials, electron beam (e-beam) for surface sterilization at high throughput, and X-ray for high-density product loads. Medical device manufacturers choose among these methods based on their device material compatibility, sterility assurance requirements, and regulatory submission specifications. ### How does STERIS's central sterile processing equipment work in hospitals? STERIS sterilizers (primarily steam autoclaves for most surgical instruments and low-temperature sterilizers for heat-sensitive items) are the core of hospital sterile processing departments. After each surgery, used instruments are cleaned, inspected, packaged in STERIS trays, and processed through sterilizers that achieve defined sterility assurance levels. STERIS also provides the washers/disinfectors, sterile processing carts, and tracking software that manage instrument lifecycle documentation required by The Joint Commission. ### What is STERIS's pharmaceutical and life sciences business? STERIS provides sterilization, decontamination, and aseptic processing services and equipment for pharmaceutical manufacturers — sterilizing drug products, containers, and manufacturing environments. Pharmaceutical-grade sterilization requires GMP (Good Manufacturing Practice) compliance and validation documentation accepted by FDA regulatory filings. STERIS's pharma services division is a high-growth segment as biologics and injectable drug manufacturing require increasingly sophisticated sterility infrastructure. ### How large is STERIS and what are its financial metrics? STERIS (NYSE: STE) generates approximately $5B in annual revenue across its Healthcare, Life Sciences, and AST segments. The company has a track record of consistent revenue growth and margin expansion, driven by procedure volume growth in hospitals and increasing outsourced sterilization by medical device manufacturers. STERIS trades at premium valuation multiples reflecting the recurring consumables and service revenue model and the mission-critical nature of hospital sterilization infrastructure. ## Tags b2b, healthtech, manufacturing, saas, public --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*